BGLC vs PHM · rev $9.5M vs P/E 7.7, rev $17.95B
BioNexus Gene Lab Corp Common stock (BGLC) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported BGLC revenue for 2024-12-31 was $9.5M. Net income was $1.6M. Revenue was down 2.7% from 2023-12-31 to 2024-12-31. BGLC currently screens at market cap $6.1M.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
BGLC currently screens at market cap $6.1M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the BGLC and PHM stock pages for the full models.
Not investment advice.